Grandeur Peak Global Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.85M | Sell |
45,406
-36,350
| -44% | -$2.53M | 0.67% | 27 |
|
|
2025
Q4 | $5.43M | Buy |
81,756
+21,730
| +36% | +$1.4M | 0.73% | 33 |
|
|
2025
Q3 | $4.04M | Buy |
60,026
+24,227
| +68% | +$1.92M | 0.54% | 47 |
|
|
2025
Q2 | $3.12M | Buy |
35,799
+4,483
| +14% | +$351K | 0.38% | 59 |
|
|
2025
Q1 | $2.14M | Sell |
31,316
-32,104
| -51% | -$2.62M | 0.24% | 72 |
|
|
2024
Q4 | $4.93M | Buy |
63,420
+10,795
| +21% | +$799K | 0.44% | 59 |
|
|
2024
Q3 | $3.53M | Buy |
52,625
+26,555
| +102% | +$2.18M | 0.29% | 77 |
|
|
2024
Q2 | $2.96M | Sell |
26,070
-621
| -2% | -$78.5K | 0.24% | 83 |
|
|
2024
Q1 | $3.7M | Sell |
26,691
-2,508
| -9% | -$315K | 0.29% | 74 |
|
|
2023
Q4 | $3.62M | Sell |
29,199
-4,524
| -13% | -$462K | 0.26% | 71 |
|
|
2023
Q3 | $3.15M | Buy |
33,723
+15,615
| +86% | +$1.76M | 0.24% | 72 |
|
|
2023
Q2 | $2.33M | Hold |
18,108
| – | – | 0.16% | 76 |
|
|
2023
Q1 | $2.1M | Buy |
18,108
+1,900
| +12% | +$213K | 0.13% | 72 |
|
|
2022
Q4 | $1.84M | Sell |
16,208
-9,890
| -38% | -$1.09M | 0.11% | 74 |
|
|
2022
Q3 | $2.1M | Buy |
26,098
+3,106
| +14% | +$263K | 0.13% | 71 |
|
|
2022
Q2 | $1.71M | Buy |
22,992
+11,020
| +92% | +$1.01M | 0.11% | 73 |
|
|
2022
Q1 | $1.53M | Buy |
11,972
+5,720
| +91% | +$626K | 0.07% | 94 |
|
|
2021
Q4 | $839K | Sell |
6,252
-800
| -11% | -$115K | 0.04% | 102 |
|
|
2021
Q3 | $964K | Sell |
7,052
-648
| -8% | -$81.7K | 0.05% | 100 |
|
|
2021
Q2 | $822K | Buy |
7,700
+2,400
| +45% | +$230K | 0.04% | 103 |
|
|
2021
Q1 | $476K | Buy |
5,300
+2,600
| +96% | +$244K | 0.03% | 111 |
|
|
2020
Q4 | $250K | Buy |
2,700
+1,200
| +80% | +$107K | 0.01% | 108 |
|
|
2020
Q3 | $155K | Sell |
1,500
-1,900
| -56% | -$199K | 0.01% | 107 |
|
|
2020
Q2 | $345K | Sell |
3,400
-700
| -17% | -$62.6K | 0.03% | 103 |
|
|
2020
Q1 | $276K | Sell |
4,100
-4,100
| -50% | -$255K | 0.03% | 105 |
|
|
2019
Q4 | $448K | Sell |
8,200
-5,600
| -41% | -$266K | 0.04% | 83 |
|
|
2019
Q3 | $515K | Hold |
13,800
| – | – | 0.06% | 87 |
|
|
2019
Q2 | $517K | Hold |
13,800
| – | – | 0.05% | 86 |
|
|
2019
Q1 | $411K | Hold |
13,800
| – | – | 0.05% | 82 |
|
|
2018
Q4 | $413K | Sell |
13,800
-3,400
| -20% | -$108K | 0.05% | 85 |
|
|
2018
Q3 | $615K | Sell |
17,200
-8,400
| -33% | -$260K | 0.06% | 85 |
|
|
2018
Q2 | $608K | Hold |
25,600
| – | – | 0.06% | 89 |
|
|
2018
Q1 | $475K | Hold |
25,600
| – | – | 0.05% | 90 |
|
|
2017
Q4 | $367K | Buy |
+25,600
| New | +$333K | 0.05% | 89 |
|
Other funds holding DXCM
VCM
VPM
Grandeur Peak Global Advisors's DXCM Position: Q1 2026 in Review
Grandeur Peak Global Advisors reduced its DexCom (DXCM) stake by 44% in Q1 2026, selling an estimated $2.53M and leaving 45,406 shares worth $2.85M. The position accounts for 0.67% of the portfolio, ranked #27.
Grandeur Peak Global Advisors first reported a position in DXCM in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.43M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Grandeur Peak Global Advisors held 45,406 shares of DexCom worth $2.85M as of Q1 2026.
- Grandeur Peak Global Advisors sold 36,350 DexCom shares in Q1 2026, an estimated $2.53M.
- DexCom made up 0.67% of Grandeur Peak Global Advisors's portfolio in Q1 2026, its #27 holding.
- Grandeur Peak Global Advisors first reported a position in DexCom in Q4 2017 and has held it in 34 quarters since.
- Grandeur Peak Global Advisors's DexCom position peaked at $5.43M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Grandeur Peak Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.